Abiologics
1 known investors
Abiologics uses generative AI and high-throughput chemical protein synthesis to design and produce Synteins, a new class of programmable, protease-resistant, immune-silent biologic therapeutics. The company targets a range of disease areas, including oncology, immunology, and metabolic diseases.
Investors · 1
In the news
Frequently asked questions
- What does Abiologics do?
- Abiologics uses generative AI and high-throughput chemical protein synthesis to design and produce Synteins, a new class of programmable, protease-resistant, immune-silent biologic therapeutics. The company targets a range of disease areas, including oncology, immunology, and metabolic diseases.
- Who are Abiologics's investors?
- Abiologics's investors include Flagship Pioneering.